EMPFIELD JAMES R.
SEC CIK 1665430 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | EVP, Drug Discovery | 75.0K | — | $3.78M | 6 | 2022-03-04 | 2022-08-12 |
Most active insiders at XENE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORTIMER IAN | Pres, CEO, INTERIM CFO, Dir | — | $21.30M |
| 2 | KENNEY CHRISTOPHER JOHN | Chief Medical Off | — | $670.3K |
| 3 | GANNON STEVEN | Dir | — | $640.6K |
| 4 | DiFabio Andrea | CLO | — | $230.8K |
| 5 | PATOU GARY | Dir | — | $70.3K |
| 6 | Cannon Gillian | Dir | — | $63.2K |
| 7 | GAROFALO ELIZABETH A. | Dir | — | — |
| 8 | Gover Justin D. | Dir | — | — |
| 9 | Svoronos Dawn | Dir | — | — |
| 10 | Machado Patrick | Dir | — | — |
EMPFIELD JAMES R. made no open-market trades at XENE in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-16 | 2022-08-12 | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | M - OptEx | $4.24 | +65.0K | 75.0K | +650% | +$275.8K |
| DM | 2022-08-16 | 2022-08-12 | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | S - Sale+OE | $38.31 | -57.7K | 31.9K | -64% | -$2.21M |
| D | 2022-08-16 | 2022-08-12 | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | F - Tax | $38.02 | -7,257 | 67.7K | -10% | -$275.9K |
| DM | 2022-03-08 | 2022-03-04+ | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | M - OptEx | $7.43 | +67.5K | 51.8K | New | +$501.4K |
| DM | 2022-03-08 | 2022-03-04+ | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | F - Tax | $30.72 | -16.3K | 42.9K | -28% | -$501.7K |
| DM | 2022-03-08 | 2022-03-04+ | XENE | Xenon Pharmaceuticals Inc. | EMPFIELD JAMES R. | EVP, Drug Discovery | S - Sale+OE | $30.63 | -51.2K | 10.0K | -84% | -$1.57M |
Purchase Sale Sale after option exercise All abbreviations